In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: A murine model for studying placental angiogenesis

Molecular Human Reproduction

Volumn 11, Issue 4, 2005, Pages 253-260

  Geva, E ^a   Ginzinger, D G ^b   Moore II, D H ^b   Ursell, P C ^c   Jaffe, R B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Angiopoietin 2; Placenta

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL REACTIVITY; CELL ADHESION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXPRESSION VECTOR; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENE TARGETING; GESTATION PERIOD; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PLACENTA CIRCULATION; PLACENTA WEIGHT; PLASTICITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOPOIETIN-2; ANIMALS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; GENETIC VECTORS; HUMANS; MICE; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PLACENTA; PREGNANCY; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

MURINAE;

EID: 18644376701     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah159     Document Type: Article

References (33)

1. Ahmed A and Perkins J (2000) Angiogenesis and intrauterine growth. Baillieres Best Pract Res Clin Obstet Gynaecol 14,981-998.
2. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD and Isner JM (1998) Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83,233-240.
3. Bowen JA and Hunt JS (1999) Expression of cell adhesion molecules in murine placentas and a placental cell line. Biol Reprod 60,428-434.
4. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D and During MJ (2004) VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 36,827-835.
5. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M and Morla AO (2001) Direct cell adhesion to the angiopoietins. J Biol Chem 276,26516-26525.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 4,435-439.
7. Cross JC (2000) Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol 11,105-113.
8. Douglas GC, Thirkill TL and Blankenship T (1999) Vitronectin receptors are expressed by macaque trophoblast cells and play a role in migration and adhesion to endothelium. Biochim Biophys Acta 1452,36-45.
9. Dunk C, Shams M, Nijar S, Rhaman M, Qiu Y, Bussolati B and Ahmed A (2000) Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156,2185-2199.
10. Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS and Arbeit JM (2001) Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 15,2520-2532.
11. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25,581-611.
12. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380,439-442.
13. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D et al. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3,411-423.
14. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A and Jaffe RB (2002) Human placental vascular development: vasculogenic and angiogenic (branching and non-branching) transformation is regulated by vascular endothelial growth factor (VEGF)-A, angiopoietin-1 and angiopoietin-2. J Clin Endocrinol Metab 87,4213-4224.
15. Goldman-Wohl DS, Ariel I, Greenfield C, Lavy Y and Yagel S (2000) Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodelling. Mol Hum Reprod 6,81-87.
16. Kingdom JC and Kaufmann P (1997) Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18,613-621.
17. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350,672-683.
18. Lobov IB, Brooks PC and Lang RA (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99,11205-11210.
19. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277,55-60.
20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111, 649-658.
21. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Metmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ et al. (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphagiogenesis as well as angiogenesis. J Exp Med 196,1497-1506.
22. Ong S, Lash G and Baker PN (2001) Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 14,969-980.
23. Rossant J and Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2,538-548.
24. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W and Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376,70-74.
25. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN and Yancopoulos G (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
26. Thirkill TL and Douglas GC (1999) The vitronectin receptor plays a role in the adhesion of human cytotrophoblast cells to endothelial cells. Endothelium 6,277-290.
27. Thurston G, Rudge IS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM and Yancopoulos GD (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6,460-463.
28. Vellman PF (1997) Data Desk Statistics Guide version 6.0. Data Description Inc., Ithaca, New York, pp 20/A-20/10.
29. Wixler V, Laplantine E, Geerts D, Sonnenberg A, Petersohn D, Eckes B, Paulsson M and Aumailley M (1999) Identification of novel interaction partners for the conserved membrance proximal region of alpha-integrin cytoplasmic domains. FEBS Letters 445,51-55.
30. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD and Isner JM (1998) Chemotactic properties and angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273, 18514-18521.
31. Wulff C, Wilson H, Dickson SE, Wiegand SJ and Fraser HM (2002) Hemochorial placentation in the primate: Expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66,802-812.
32. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407,242-248.
33. Zhou Y, Bellingard V, Feng KT, McMaster M and Fisher SJ (2003) Human cytotrophoblasts promote endothelial survival and vascular remodelling through secretion of Ang2, PIGF, and VEGF-C. Dev Biol 263,114-125.